- Alternative Medicine
- Mesothelioma Cure
- Mesothelioma Research
- Mesothelioma Doctors
- Mesothelioma Cancer Centers
- Mesothelioma Clinical Trials
Over 30 Billion dollars in trust fund money has been set aside for asbestos victims.
Get a Free copy of Surviving Mesothelioma, Lean on Me, or 100 Questions & Answers About Mesothelioma
Mesolink.org now offeres Free Assistance with VA Claims and other benefits.
Dr. Philippe A Chahinian
Dr. Philippe A. Chahinian is a Professor of Medicine at the Mount Sinai School of Medicine in New York City, and is also a top oncologist and mesothelioma expert practicing at Mount Sinai’s Derald H. Ruttenberg Treatment Center.
Dr. Chahinian is a specialist in internal medicine as well as in the treatment of mesothelioma patients. Mesothelioma is a rare cancer caused by exposure to asbestos. Dr. Chahinian’s expertise is very important to the people of New York. At least 400 public state buildings, workplaces, and other facilities such as shipyards and oil refineries in New York have been tested and confirmed for asbestos exposure. This list even includes restaurants and homes. Hundreds of buildings in New York that have not yet been identified as containing asbestos are still potential risks. The 2001 terrorist attacks on the World Trade Center also presents a risk of asbestos exposure to citizens of New York City. Over 400 people have died from mesothelioma in New York City in the last 20 years.
Dr. Chahinian received his medical degree from the Paris School of Medicine in 1969. He completed his residency in 1974 at Paris University, after which he came to the United States and received a fellowship from Mount Sinai Hospital in 1976. Mount Sinai is the one of the biggest volunteer teaching hospitals in the country and has a staff of 1800 medical professionals.
Dr. Chahinian’s current practice at the Ruttenberg Treatment Center at Mount Sinai focuses on the treatment of mesothelioma patients, along with other thoracic cancers, lung cancer and thymoma. He supports his mesothelioma specialty by concentrating on medical oncology as a sub-specialty.
His expertise in mesothelioma and oncology, as well as in general internal medicine, has been demonstrated in a number of published articles and papers. Dr. Chahinian was also the co-editor of a book called “Mesothelioma” and co-authored a book about lung cancer. He has been interviewed for several publications, including New York Magazine, and is a sought-after speaker. He most recently acted as the moderator of the 2008 Chemotherapy Foundation Symposium.
Dr. Chahinian can be contacted through the Mount Sinai Medical Center at the Ruttenberg Treatment Center on Fifth Avenue.